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From HIV infection to AIDS:
A dynamically induced percolation transition?
Christel Kamp∗ and Stefan Bornholdt
Institut fu¨r Theoretische Physik, Universita¨t Kiel, Leibnizstraße 15, D-24098 Kiel, Germany
The origin of the unusual incubation period distribution in the development of AIDS is largely
unresolved. A key factor in understanding the observed distribution of latency periods, as well
as the occurrence of infected individuals not developing AIDS at all, is the dynamics of the long
lasting struggle between HIV and the immune system. Using a computer simulation, we study the
diversification of viral genomes under mutation and the selective pressure of the immune system.
In common infections vast spreading of viral genomes usually does not takes place. In the case of
an HIV infection this may occur, as the virus successively weakens the immune system by depletion
of CD4+ cells. In a sequence space framework, this leads to a dynamically induced percolation
transition, corresponding to the onset of AIDS. As a result, we obtain the prolongated shape of the
incubation period distribution, as well as a finite fraction of non-progressors that do not develop
AIDS, comparing well with results from recent clinical research.
It is a well known empirical fact that incubation times
of most diseases obey a lognormal distribution, only vary-
ing in their distributions’ mean and dispersion factors.
This has been verified for many single-exposure, common
vehicle epidemics and is often referred to as “Sartwell’s
model” [1,2]. Vice versa, this allows for estimates of ex-
posure types as well as etiology of disease from an ob-
served incubation period distribution [3–5]. Recently,
the underlying dynamics that generate the incubation
period distribution, as well as mechanisms that lead to
deviations from the common distribution, have gained
attention [6–8].
One of the most prominent examples for a deviation from
the lognormal case is the distribution of waiting times
between HIV infection (seroconversion) and the onset
of AIDS, which is supported by data sets from various
studies [9–14]. The divergence from lognormality, ex-
traordinarily long incubation times, and the occurrence
of non-progressors (patients not developing AIDS) sug-
gest a more complex generating dynamics than observed
in other infectious diseases. While much effort has been
spent on parametric estimates of the incubation period
distribution [15], we here ask which are possible mech-
anisms of the underlying dynamics. Any such attempt
has to take into account the HIV-specific negative feed-
back to the host’s immune system. While the immune
system develops an epitope-specific answer to HIV, as it
does to any other antigenic invasion, it is weakened by
HIV in a way that is not common to other viral infec-
tions. HIV targets the replicative machinery of CD4+
cells which are depleted when viruses proliferate. CD4+
cells as T helper cells are essential actors within an im-
mune response. Therefore HIV is able to globally weaken
the host’s resistance against antigens.
In earlier approaches, the onset of AIDS has been associ-
ated with the passage of an antigenic diversity threshold
in the framework of differential equation models [16,17].
More recently, progress has been made to overcome the
limitations of analytical models with respect to topologi-
cal effects in the shape space of receptors and in physical
space. Cellular automaton models have been defined and
investigated that show the typical separation between the
time scales of primary infection and the onset of AIDS
[18,19].
In this article we take an alternative approach and com-
bine cellular automata with a sequence space frame-
work in order to model typical characteristics of the time
course of HIV infection. In the following sections we will
first define a framework to represent ordinary infections
within the scope of percolation theory. From there we
will extend the model to describe the special case of HIV
infection and discuss the distribution of incubation peri-
ods. Numerical simulations will be complemented by a
stochastic model for the origin of the variety in incuba-
tion period distributions. Finally we discuss our findings
in the context of empirical data on HIV survival.
I. PERCOLATION MODEL OF INFECTION
Along the course of an infection one generally observes
a diversification of viral genomes due to mutation and
the selective pressure of the immune system. This co-
evolutionary dynamics can be modeled within a sequence
space framework [20]. Representing viral genomes by
strings of length n, built up from an alphabet of length
λ, we can describe their diversification as spread in se-
quence space. Analogously, let us assign a sequence to
the respective immune receptor matching the viral strain.
Any string in sequence space is assumed to represent a
viral epitope, as well as its complementary immune re-
ceptor. Thus each sequence is characterized by a viral
and an immunological state variable. A mathematical
framework to describe the dynamics in such a space can
be found in percolation theory [21] and in theories for
epidemic spreading, i.e. SIR models [22,23]. However,
while those models apply cellular automata to the in-
teraction of organisms, we here apply the mathematical
1
concept to modeling the populations of immune cells and
viruses within one organism. Adopting the notation of
SIR models, we call a site in sequence space susceptible,
if it in principle can harbor a virus. It is denoted as
infected, if the system contains a virus with an epitope
motif represented by the site’s string. If a viral sequence
meets immune response it is removed and the system is
immunized against it. In this case and in case a site in
principle is inaccessible for a virus, it is called recovered
(or removed). Aside from this, two immunological states
are distinguished. An immune receptor shape may or
may not be present within the immune repertoire. We
set up a system in which a site is inaccessible for viral se-
quences with probability D0 accounting for the fact that
the viral genome is not arbitrary. In addition we intro-
duce a probability of immunological presence at any site
in sequence space ρis(t) with ρis(0) = ρ0. This means
that for sufficiently large systems the initial density of
recovered sites is R(0) = D0 + ρ0 − D0ρ0. Taking also
into account the densities of susceptible sites S(t) and of
infected sites ρv(t) one obtains the relation
S(t) + ρv(t) +R(t) = 1 ∀t. (1)
As replication of viral and immunological entities is af-
flicted with copy fidelities qv < 1 and qis < 1, the system
shows viral - and in response immunological - spread in
sequence space. Introducing some viral strains into a so
far unaffected system leads to a dynamics that is mod-
eled within the cellular automaton approach by iterating
the following steps:
1. Choose a random site.
2. If the site represents an active immune receptor
(a) mutate any bit with probability 1− qis
(b) if a new immunological strain is generated and
the mutant matches an infected site reset the
site’s viral status to recovered and assign the
immunological state to be positive.
3. If the site is infected
(a) mutate any bit with probability 1− qv
(b) if a new strain is generated and corresponds
to a susceptible site the site gets infected.
A viral strain generates a specific mutant strain at Ham-
ming distance d (which is the number of differing bits)
with probability
(1−qv)
dqn−dv
(λ−1)d
which will survive as long
as it meets a susceptible site. Equally an immunological
mutant strain is originated with probability
(1−qis)
dq
n−d
is
(λ−1)d
under the condition that it coincides with an infected site.
Otherwise we assume that the immunological mutant is
not sufficiently amplified to establish a new strain.
Such a system shows two regimes of qualitatively dif-
ferent behavior. Below a percolation threshold depend-
ing on the above parameters the source of infection will
stay negligible in size compared to the system size, such
that R(∞) = R(0) in the limit of infinite system size.
Above the percolation threshold a virus will spread all
over the system before it gets defeated. Accordingly
R(∞) > R(0).
To determine the threshold conditions within a mean
field approach (“fully mixed” approximation), we intro-
duce the following system of differential equations
dS
dt
= −
n∑
d=1
(
n
d
)
(λ − 1)d (1− qv)
dqn−dv
(λ− 1)d ρvS
= −(1− qnv )ρvS (2)
dρv
dt
= −(1− qnis)ρisρv + (1− qnv )Sρv (3)
dρis
dt
= (1− qnis)ρvρis (4)
dR
dt
= (1− qnis)ρisρv (5)
supplemented by the boundary conditions:
S(0) ≈ 1−R(0)
ρv(0) ≈ 0
ρis(0) = ρ0
R(0) = D0 + ρ0 −D0ρ0.
With (1−qnis)ρis(t) > 0 for all t and ρis(t) = R(t)−D0+
D0ρ0 one can derive a relation between S(t) and R(t)
dS
dt
= − 1− q
n
v
1− qnis
dR
dt
R−D0 +D0ρ0
S
which yields
S(t)=(1−D0 − ρ0 +D0ρ0)
(
ρ0
R(t)−D0 +D0ρ0
)1−qnv
1−qn
is
(6)
taking into account the above boundary conditions. To
evaluate conditions for the percolation threshold we can
utilize
R∞ = R(∞) = 1− S(∞) = 1− S∞
because in the stationary state any infected site will re-
cover. This leads to the following relation for R∞
R∞=1− (1 −D0 − ρ0 +D0ρ0)
(
ρ0
R∞−D0 +D0ρ0
)1−qnv
1−qn
is
=f(R∞). (7)
It is fulfilled for R∞ = D0 + ρ0 − D0ρ0 = R(0) which
means that no virus enters the system or at least cannot
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gain macroscopic areas in sequence space. However, the
above equation has another solution if
d
dR∞
f(R∞)|R∞=R(0) > 1,
because f(R(0)) = R(0), limR∞→∞ f(R∞) = 1,
f(R∞) < 1 ∀R∞ <∞. Evaluating the above condition
leads to the result that an invading virus can percolate
in sequence space if
1− qnv
1− qnis
>
ρ0
1−R(0) . (8)
It is worthwhile to consider the case qis → 1 which im-
plies that the above inequality holds for any R(0) < 1.
If the immune cells have vanishing mutation rates and
accordingly lack adaptability, the virus percolates the se-
quence space in any case - unless immune cells occupy
any site in sequence space.
For
1−qnv
1−qn
is
= 1 we can explicitly determine the asymp-
totic density of recovered cells from the fixed point equa-
tion (7) that is solved by R∞ = 1 − ρ0 and R∞ =
D0 + ρ0 −D0ρ0 = R(0). With the additional constraint
that R∞ ≥ R(0) one can see that R∞ decays linearly
with increasing ρ0 until it is equal to R(0) and the sub-
critical regime is reached. This is confirmed by computer
simulations with various sets of parameters. For the ex-
ample of D0 = 0.5, qv = qis = 0.95, n = 15, λ = 2 this
leads to a critical immunological density ρc0 = 0.32 (the
theoretical value from equation (8) is ρc0 =
1
3 ).
Obviously in common infections the system is below the
percolation threshold as an adequate immune response
can defeat a viral attack before strains spread all over
sequence space. Nonetheless it is not unreasonable to
assume that the immune system operates near the per-
colation threshold as unnecessarily high immune receptor
densities ρ0 involve competitive disadvantages.
II. PERCOLATION TRANSITION FROM HIV
INFECTION TO THE ONSET OF AIDS
We are now in the position to extend our model to
include HIV dynamics. An HIV model has to take care
of characteristic peculiarities of HIV infections, i.e. the
destruction of the immune system by the virus. We con-
sider this by extending the algorithm of section I by the
following rule: At any iteration step each viral strain is
given a chance to meet a random immunological clone
with probability ρis(t) which thereafter is destroyed with
probability p. If the affected site in principle is acces-
sible for a viral strain the viral status changes back to
susceptible. We initialize the system near, but below
the percolation threshold, which is the natural state of
a healthy immune system. As the system’s qualitative
behavior shows to be insensitive to the specific choice of
parameters we will in the following choose the parameter
settings: D0 = 0.5, ρ0 = 0.325, qv = qis = 0.95, n = 15,
λ = 2.
ρv(t)
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FIG. 1. Density of viral strains ρv(t) in sequence space
under evolution of the system (D0 = 0.5, ρ0 = 0.325,
qv = qis = 0.95, n = 15, λ = 2, p = 0.0001).
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FIG. 2. Density of immunologically active sites ρis(t) in
sequence space (D0 = 0.5, ρ0 = 0.325, qv = qis = 0.95,
n = 15, λ = 2, p = 0.0001). Note the analogy to the decline
in CD4+ cells under HIV infection.
Figures 1 and 2 show simulation results for p = 0.0001
exhibiting characteristics typical to the course of disease
from HIV infection to the onset of AIDS. One observes a
drift of viral epitopes due to immune pressure as found
in HIV-infected individuals [24–30]. Moreover, the sim-
ulations show fluctuations in the total number of actual
strains, eventually sharply increasing which corresponds
to the onset of AIDS [16]. In parallel it is an empirical
fact that the disease progresses with a depletion of CD4+
cells [31,32,25,33] which can be assumed to be accompa-
nied by a loss in diversity of the immune repertoire as
shown in figure 2. In this picture the immune system is
successively weakened while fighting the viral attack and
ultimately breaks down when the virus begins to perco-
late in sequence space. The virus dynamically drives the
3
system from a subcritical regime above the percolation
threshold.
It will be interesting to investigate the distribution of
waiting times until percolation among systems only dif-
fering in their random initialization, which corresponds
to the incubation period distribution.
To understand the generated distribution from a theoret-
ical point of view we have to take care of the stochastic
nature of ρv as seen in figure 1. We assume that ρv has
a time dependent growth rate r(t) that is superposed
by noise and accordingly follows a generalized geometric
Brownian motion (cp. appendix). This process ρv has a
lower absorbing boundary for ρv(t) = 2
−15 and converts
into exponential growth after having passed an upper
point of no return ρcv. The first passage time distribution
with respect to the upper boundary corresponds to the
incubation period distributions under investigation. It
is derived in the appendix and will be discussed in the
context of simulation results and empirical HIV data in
the following section.
III. RESULTS AND DISCUSSION
We have run simulations as described in section II for
various sets of parameters qualitatively leading to the
same results for the time course of ρv and ρis, as long as
the system is initialized near but below the percolation
threshold. For the following discussion let us choose the
parameter settingsD0 = 0.5, ρ0 = 0.325, qv = qis = 0.95,
n = 15, λ = 2. The virgin system is infected within
a ball that includes one and two bit mutants leading
ρv(0) = 2
−15(1+
(
15
1
)
+
(
15
2
)
)(1−D0−ρ0+D0ρ0) ≈ 0.0012.
A lower absorbing boundary of ρv is given by 2
−15 as less
than one viral strain cannot exist. Further evaluation of
the simulations yields estimates of ρcv = 0.002 where the
virus begins to percolate. Taking this together, we will
be able to analyze the simulation results from the point
of view of first passage time distributions (cp. appendix).
We have run simulations for various choices of p mimic-
ing viruses with different aggressiveness towards the im-
mune system. For p as large as 0.005 we hardly see any
time period of struggle between the immune system and
the virus leading to an immediate exponential growth of
ρv. The system shows very short incubation periods and
vanishing probability of viral defeat. The distribution of
incubation periods can then be approximated by a sim-
ple inverse Gaussian distribution. Decreasing p leads to
longer incubation periods that correspond to periods of
combat between virus and immune system as observed
in figure 1.
For further discussions we will focus on simulations with
p = 0.0001 as they show a distribution of incubation pe-
riods that are in best accordance with real data on HIV
incubation periods. Nonetheless the theoretical frame-
work as developed in the appendix will be equally appli-
cable for arbitrary choice of p.
Figure 3 offers a comparison of a survival function gen-
erated by our cellular automaton model with the respec-
tive data describing the probability that a HIV positive
patient has not yet developed AIDS at time t after sero-
conversion. The HIV data are taken from a seroconverter
study undertaken at the Robert Koch Institut within the
CASCADE collaboration [34].
Fract.
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]
FIG. 3. Comparison of the probability for HIV positives
not yet to have developed AIDS with a survival distribution
generated by our simulations (after adequate renormalization
of the time axis, D0 = 0.5, ρ0 = 0.325, qv = qis = 0.95,
n = 15, λ = 2, ρv(0) = 0.0012, ρ
c
v = 0.002).
Figure 3 shows that the model reproduces main charac-
teristics of the real system. The numerical simulations re-
sult in a survival function that is similar to that observed
from HIV patients. In particular, they predict the occur-
rence of long-term survivors as observed in reality and
link it to a dynamical percolation mechanism. We would
like to emphasize that in this framework a quantitative
comparison of our model parameters with experimental
data is not very meaningful. However, any parameter
setting that corresponds to a system that is initially be-
low the percolation threshold and that is attacked with
moderate aggressiveness (moderate values of p) will show
the same qualitative behavior. This demonstrates the
robustness of our model and ensures its applicability to
even larger sequence spaces than those simulated here.
Furthermore let us analyze the data in the light of the
first passage time distributions derived in the appendix.
We have to specify the functional from of the viral growth
rate r(t). Different from the case of a very aggressive
virus (large p), a constant growth rate r(t) = µ > 0
does not fit the simulation results for viruses that are
only moderately destructive (small p). Therefore let us
approximate r(t) underlying the simulations by an ex-
pansion in powers of t as
r(t) = µ+ γt.
Such a simple approach may not exactly reproduce the
4
waiting time distribution but can show the origin of its
characteristics. This is exemplified by figure 4 where the
incubation period distributions corresponding to the sur-
vival curves shown in figure 3 are approximated by a first
passage time distribution with µ = 0.064, γ = −0.0092
and σ2 = 0.0091. This corresponds to the picture that
the viral species initially is able to establish new strains
but that its opportunities for spreading in sequence space
are successively diminished. In many cases the virus nev-
ertheless is able to percolate sequence space if its sup-
pression takes effect too slowly. This happens in a non-
deterministic manner due to stochastic fluctuations cor-
responding to σ2 > 0 and generates the observed incu-
bation period distribution.
IPD
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0 5 10 15 20 25 30
HIV incubation period distribution
Simulation results
Fit of theoretical distribution
t [years], [ Iterations
13.5×215
]
FIG. 4. Comparison of the incubation period distributions
(IPD) corresponding to figure 3 with the theoretical model
with r(t) = 0.064 − 0.0092t, σ2 = 0.0091.
Limitations of the linear approximation become obvi-
ous with increasing t. r(t) is unbounded for negative
numbers leading to arbitrarily large destruction of viral
strains with time. As a consequence, the corresponding
incubation period distribution shows an unrealistic cut-
off for large t. This disappears when considering further
terms in the expansion of r(t) expanding the regime of
applicability of the theoretical model.
Describing the behavior of incubation periods within our
model we can summarize that one observes an increase
in waiting times before percolation and an enlarged frac-
tion of cases where viral strains get totally extinct with
decreasing p, i.e. less aggressive viral strains. This finds
clear correspondence in real HIV statistics. p is a mea-
sure for the vulnerability of the immune system under
the attack of HIV. This virus manages its destructive
penetration into T helper cells (CD4+ cells) not only by
membrane fusion mediated by CD4 but generally needs
an additional co-receptor which is referred to as CCR5.
As almost all HIV strains rely on this mechanism for
replication in T cells, individuals who show a homozy-
gous mutation leading to a non-expression of the CCR5
receptor have proven to be resistant against HIV infec-
tion [35]. This is well in accordance with our model which
for p = 0 predicts that no percolation will occur. More
recently it has been shown that also in individuals with
heterozygous genotypes a slower progression to AIDS can
be observed. Moreover those patients have a 70% re-
duced risk to maintain the HIV infection and develop
AIDS [36]. Therefore, already a reduction of CCR5 re-
ceptors on CD4+ cells, making viral fusion more difficult,
improves the chance for prolonged or even total survival.
This fits well with the predictions of the model for de-
crease in p.
Recent progress in vaccine research [37–39] further sup-
ports the model. From the model’s point of view, vacci-
nation corresponds to a local raise of immune receptors’
density ρ0. This drives the system far below the percola-
tion threshold and accordingly HIV will hardly manage
to spread in sequence space.
In conclusion the above HIV/AIDS phenomenology can
be interpreted within our cellular automaton model.
Prolonged survival as well as a finite fraction of non-
progressors can be traced back to the enhanced stability
below the percolation transition in this framework. Con-
sequently, from the percolation model’s point of view,
vaccination and receptor blocking are encouraged as effi-
cient strategies to overcome an HIV infection.
C.K. would like to thank the Stiftung der Deutschen
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APPENDIX:
First passage time distributions for geometric
Brownian motion between two absorbing boundaries
Facing the stochastic nature of ρv(t) we choose an
ansatz in the regime before the percolation transition
that expects a time dependent viral growth rate r(t) of
ρv(t) which is superposed by noise. In terms of a stochas-
tic differential equation this can be written as
dρv(t) = r(t)ρv(t)dt+ ρv(t)dBt(0, σ
2) (9)
with Bt(0, σ
2) denoting Brownian motion with mean 0
and variance σ2t. Within the Stratonovich interpretation
[40] this equation leads to
ρv(t) = ρv(0)e
R(t)+Bt(0,σ
2) (10)
R(t) =
∫ t
0
r(t′)dt′. (11)
Accordingly ρv is described by geometric Brownian mo-
tion that is locked between two absorbing boundaries at
2−n (less than one strain cannot exist) and an upper criti-
cal concentration ρcv that leads to percolation of the virus.
This can be translated to Brownian motion Bt(R(t), σ
2)
5
(mean R(t) and variance σ2t) with B0 = 0 and limited
by
−a = ln
(
2−n
ρv(0)
)
< 0
b = ln
(
ρcv
ρv(0)
)
> 0.
The probability density p(x, t) describing the distribution
of the stochastic variable Bt(R(t), σ
2) is determined by
the following Fokker-Planck equation [41,42]
∂p(x, t)
∂t
= −r(t) ∂
∂x
p(x, t) +
σ2
2
∂2
∂x2
p(x, t) (12)
= − ∂
∂x
J(x, t) (13)
J(x, t) = r(t)p(x, t) − σ
2
2
∂
∂x
p(x, t). (14)
J(−a, t) and J(b, t) represent the contributions of the
probability flow being absorbed at the boundaries−a < 0
and b > 0 at time t. In other words J(b, t)dt is the
probability that Bt(R(t), σ
2) reaches b for the first time
in [t, t + dt[ under the additional condition that it has
not yet met the absorbing boundary at −a. However,
this means that J(b, t) is equivalent to the first passage
time distribution of the process ρv(t) with respect to the
upper boundary ρcv, again requiring that it has not passed
the lower absorbing boundary at 2−n. Note that J(b, t)
represents a defective probability distribution in t as the
upper boundary is not reached with probability 1.
Accordingly it remains to solve (12) with respect to the
following initial and boundary conditions:
p(x, 0) = δ(x) ∀x ∈ [−a, b]
p(−a, t) = 0 ∀t
p(b, t) = 0 ∀t.
Having the reflection principle in mind one can derive a
solution under this conditions as an adequate superposi-
tion of Gaussian distributions [41–43]. From this one can
easily deduce using (14)
J(b, t)=
F (a, b, σ2t)√
2piσ2t3
e−
(b−R(t))2
2σ2t (15)
F (a, b, σ2t)=
e
2b(a+b)
σ2t
(
−a(1− e− 2b(a+b)σ2t )+b(e 2a(a+b)σ2t − 1)
)
e
2(a+b)2
σ2t − 1
a→∞−→ b.
Obviously, in case of only one absorbing boundary (and
r(t) = µ, R(t) = µt) we get the inverse Gaussian dis-
tribution as a well known solution for this special prob-
lem [44]. A parameter setting of D0 = 0.5, ρ0 = 0.325,
qv = qis = 0.95, n = 15, λ = 2, ρv(0) = 2
−15(1 +
(
15
1
)
+(
15
2
)
)(1−D0−ρ0+D0ρ0) ≈ 0.0012 as discussed in section
III leads to a = 3.7 and b = 0.51.
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